Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jun;29(6):1429-31.
doi: 10.1038/leu.2015.2. Epub 2014 Jan 8.

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

M P Purdue  1 , Q Lan  2 , T J Kemp  3 , A Hildesheim  2 , S J Weinstein  2 , J N Hofmann  2 , J Virtamo  4 , D Albanes  2 , L A Pinto  3 , N Rothman  2
Affiliations
Comparative Study

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

M P Purdue et al. Leukemia. 2015 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Associations between serum sCD23 and sCD30 and future risk of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and diffuse large B cell lymphoma (DLBCL), overall and by period of follow-up
Odds ratios (represented by circles) and corresponding 95% confidence limits (represented by vertical bars) are shown from comparisons of medium (middle circle) and high (bottom circle) vs. low (reference; top circle) analyte concentrations. The analyte category cutpoints are provided in Table 1. Odds ratios computed through polytomous regression with adjustment for age, year of phlebotomy, number of prior controlled thaws, and cigarette pack-years. P-values are from test of trend.
See this image and copyright information in PMC

References

    1. Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA. Non-Hodgkin Lymphoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. 3. New York: Oxford University Press, New York, NY, USA; 2006. pp. 898–918.
    1. Gu Y, Shore RE, Arslan AA, Koenig KL, Liu M, Ibrahim S, et al. Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control. 2010;21:1323–1333. - PMC - PubMed
    1. Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY, et al. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood. 2009;114:2730–2732. - PMC - PubMed
    1. Vermeulen R, Hosnijeh FS, Portengen L, Krogh V, Palli D, Panico S, et al. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population. Cancer Epidemiol Biomarkers Prev. 2011;20:1925–1927. - PubMed
    1. Purdue MP, Lan Q, Bagni R, Hocking WG, Baris D, Reding DJ, et al. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer Res. 2011;71:4898–4907. - PMC - PubMed